Search Immortality Topics:

Page 11234..1020..»

Category Archives: Genetic Therapy

Sensorineural hearing loss – Wikipedia

Sensorineural hearing loss (SNHL) is a type of hearing loss, or deafness, in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII). SNHL accounts for about 90% of reported hearing loss. SNHL is generally permanent and can be mild, moderate, severe, profound, or total Continue reading

Posted in Genetic Therapy | Comments Off on Sensorineural hearing loss – Wikipedia

Fundraiser by Glenn O’Neill : Saving Eliza

Please visit our new campaignto continue supporting the fight for children with Sanfilippo Syndrome. The campaign on this page is no longer accepting donations due to GoFundMe changing payment processors. Please visit the new page at http://www.SavingEliza.comAll funds go toward the mission of our non-profit 501c3 Cure Sanfilippo Foundation (Tax ID: 46-4322131), which is to advocate for and fund research directed toward a cure or treatment options for children with Sanfilippo Syndrome. Continue reading

Posted in Genetic Therapy | Comments Off on Fundraiser by Glenn O’Neill : Saving Eliza

Gene Therapy Archives | Genetic Literacy Project

Hundreds of clinical trials are underway studying the technologys potential use in a wide range of genetic disorders, cancer and HIV/AIDS. There is some debate over whether or not the US already has approved its first gene therapy treatment. In August 2017, the Food and Drug Administration (FDA) approved a cancer therapya CAR-T treatment marketed as Kymriahthat uses a patients own T cells and is a variation of the gene therapy that is being developed to treat single-gene diseases. Continue reading

Posted in Genetic Therapy | Comments Off on Gene Therapy Archives | Genetic Literacy Project

Challenge Awards-Class of 2017 | Prostate Cancer Foundation

Douglas McNeel, MD, PhD 2017 Movember Foundation Distinguished Gentlemans Ride PCF Challenge Award ($1 Million) Principal Investigators: Douglas McNeel, MD, PhD (University of Wisconsin) Co-Investigators: Glenn Liu, MD (University of Wisconsin), Robert Jeraj, PhD (University of Wisconsin), Christos Kyriakopoulos, MD (University of Wisconsin) Project Title: Broadening T-Cell Activation with PD-1 Blockade to Treat Advanced, Metastatic Prostate Cancer Description: What this means to patients: Treatment strategies that effectively activate the immune system to target cancer will provide a promising new therapeutic opportunity for men with prostate cancer. Continue reading

Posted in Genetic Therapy | Comments Off on Challenge Awards-Class of 2017 | Prostate Cancer Foundation

Brain Disorders and Therapy- Open Access Journals

NLM ID: 101587502Index Copernicus Value: 62.25 Brain Disorders & Therapy is a peer reviewed scientific journal known for rapid dissemination of high-quality research. Continue reading

Posted in Genetic Therapy | Comments Off on Brain Disorders and Therapy- Open Access Journals

Sanofi Initiates Phase 2 Clinical Trial to Evaluate …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sanofi Genzyme, the specialty care global business unit of Sanofi,today announced the start of a Phase 2 trial of an investigational oral therapy for patients with Parkinsons disease who carry a single copy of a gene mutation that is the most common genetic risk factor for the disease. The trial will assess the drugs dynamics, efficacy and safety. This is the first industry-sponsored Phase 2 clinical trial in a genetically defined population of Parkinsons disease. Continue reading

Posted in Genetic Therapy | Comments Off on Sanofi Initiates Phase 2 Clinical Trial to Evaluate …